Poland· PL-100500408
octenisept Vaginalspray
A octenidin, kombinationen product containing octenidini dihydrochloridum + phenoxyethanolum, registered in Poland by Schülke & Mayr GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Octenidini dihydrochloridum + Phenoxyethanolum
- Manufacturer
- Schülke & Mayr GmbH
- Country
- Poland (PL)
- ATC code
- G01AX66
- ATC class
- Octenidin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991600440
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9b2fe12e-5ef5-4894-9b54-ec2665d3f1aa GET /v1/drugs/9b2fe12e-5ef5-4894-9b54-ec2665d3f1aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór dopochwowy",
"source": "urpl",
"strength": "1 mg/ml + 20 mg/ml",
"packaging": "05909991600440 ¦ OTC ¦ 166957\n1 butelka 50 ml",
"substance": "Octenidini dihydrochloridum 1 mg/ml + Phenoxyethanolum 20.09 mg/ml",
"common_name": "Octenidini dihydrochloridum + Phenoxyethanolum",
"pl_product_id": "100500408",
"pozwolenie_nr": "29606",
"auth_procedure": "DCP",
"authorisation_validity": "2031-05-06"
}See everything about octenidin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.